Source: NANOMEDICINE. Unidade: IF
Subjects: NANOPARTÍCULAS, DIAGNÓSTICO
ABNT
NEGRÃO, Cyro von Zuben de Valega et al. HER2 aptamer-conjugated iron oxide nanoparticles with PDMAEMA-b-PMPC coating for breast cancer cell identification. NANOMEDICINE, n. 3, 2024Tradução . . Disponível em: https://doi.org/10.2217/nnm-2023-0225. Acesso em: 16 nov. 2024.APA
Negrão, C. von Z. de V., Cerize, N. N. P., Justo-Junior, A. da S., Liszbinski, R. B., Meneguetti, G. P., Araujo, L., et al. (2024). HER2 aptamer-conjugated iron oxide nanoparticles with PDMAEMA-b-PMPC coating for breast cancer cell identification. NANOMEDICINE, ( 3). doi:10.2217/nnm-2023-0225NLM
Negrão C von Z de V, Cerize NNP, Justo-Junior A da S, Liszbinski RB, Meneguetti GP, Araujo L, Rocco SA, Gonçalves K de A, Cornejo DR, Leo P, Perecin C, Adamoski D, Dias SMG. HER2 aptamer-conjugated iron oxide nanoparticles with PDMAEMA-b-PMPC coating for breast cancer cell identification [Internet]. NANOMEDICINE. 2024 ;( 3):[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/nnm-2023-0225Vancouver
Negrão C von Z de V, Cerize NNP, Justo-Junior A da S, Liszbinski RB, Meneguetti GP, Araujo L, Rocco SA, Gonçalves K de A, Cornejo DR, Leo P, Perecin C, Adamoski D, Dias SMG. HER2 aptamer-conjugated iron oxide nanoparticles with PDMAEMA-b-PMPC coating for breast cancer cell identification [Internet]. NANOMEDICINE. 2024 ;( 3):[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/nnm-2023-0225